Annual EBITDA
-$376.16M$142.66M-61.10%
Summary
- Current Value
- As of today, RNA annual EBITDA is -$376.16M, down -61.10% on
- Historical Performance
- RNA annual EBITDA is down -220.38% over the past 3 years, and down -2112.84% over the past 5 years
- All-Time High Comparison
- RNA annual EBITDA is currently -3618.83% below its historical high of -$10.12M set on
- 3-Year Low Comparison
- RNA annual EBITDA is at its 3-year low
- Sector Comparison
- RNA annual EBITDA is higher than 2.97% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$376.16M | -61.1% | -220.4% | -2112.8% | -3618.8% | |
| Quarterly EBITDA | -$187.75M | -92.7% | -321.6% | -1552.0% | -9194.5% | |
| TTM EBITDA | -$609.06M | -89.1% | -273.6% | -1721.3% | -10000.0% | |
| Price | $72.37 | +135.0% | +264.9% | +185.8% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $10.90M | +14.0% | +16.9% | +369.9% | +2775.2% | |
| Annual EPS | -$2.89 | +0.6% | -1.4% | -338.1% | -866.0% | |
| Annual EBIT | -$378.94M | -60.8% | -221.0% | -2084.4% | -3509.6% | |
| Annual Net Income | -$322.30M | -51.9% | -173.1% | -1203.1% | -2773.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$177.53M | N/A | -111.9% |
| 5Y | -$43.77M | N/A | -759.3% |
| All | -$10.12M | -3618.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$376.16M | at low | |
| 5Y | -$376.16M | at low | |
| All | -$376.16M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$376.16M | -61.1% | |
| -$233.50M | -31.5% | |
| -$177.53M | -51.2% | |
| -$117.41M | -168.2% |
| Year | Value | Change |
|---|---|---|
| -$43.77M | -157.5% | |
| -$17.00M | -68.1% | |
| -$10.12M | - |
FAQ
What is the current annual EBITDA of RNA?
As of today, RNA annual EBITDA is -$376.16M
What is 1-year change in RNA annual EBITDA?
RNA annual EBITDA is down -61.10% year-over-year
What is 3-year change in RNA annual EBITDA?
RNA annual EBITDA is down -220.38% over the past 3 years
How far is RNA annual EBITDA from its all-time high?
RNA annual EBITDA is currently -3618.83% below its historical high of -$10.12M set on December 31, 2018
How does RNA annual EBITDA rank versus sector peers?
RNA annual EBITDA is higher than 2.97% of companies in Healthcare sector
When is RNA next annual earnings release?
The next annual earnings release for RNA is on
Quarterly EBITDA
-$187.75M$17.42M-10.23%
Summary
- Current Value
- As of today, RNA quarterly EBITDA is -$187.75M, down -10.23% on
- Historical Performance
- RNA quarterly EBITDA is down -92.71% year-over-year, and down -321.64% over the past 3 years
- All-Time High Comparison
- RNA quarterly EBITDA is currently -9194.55% below its historical high of -$2.02M set on
- 3-Year Low Comparison
- RNA quarterly EBITDA is at its 3-year low
- Sector Comparison
- RNA quarterly EBITDA is higher than 0.81% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$187.75M | -10.2% | -92.7% | -321.6% | -1552.0% | |
| Annual EBITDA | -$376.16M | – | -61.1% | -220.4% | -2112.8% | |
| TTM EBITDA | -$609.06M | -17.4% | -89.1% | -273.6% | -1721.3% | |
| Price | $72.37 | +54.1% | +135.0% | +264.9% | +185.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $12.48M | +224.3% | +434.0% | +402.6% | +614.5% | |
| Quarterly EPS | -$1.27 | -4.2% | -94.1% | -54.0% | -313.8% | |
| Quarterly EBIT | -$188.81M | -10.3% | -92.4% | -320.2% | -1546.7% | |
| Quarterly Net Income | -$174.44M | -10.9% | -117.0% | -300.1% | -1425.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$120.25M | N/A | -56.1% |
| 3Y | -$51.37M | -265.5% | |
| 5Y | -$16.18M | N/A | -1060.5% |
| All | -$2.02M | -9194.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$187.75M | at low | |
| 3Y | -$187.75M | at low | |
| 5Y | -$187.75M | at low | |
| All | -$187.75M | at low |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RNA?
As of today, RNA quarterly EBITDA is -$187.75M
What is RNA quarterly EBITDA most recent change?
RNA quarterly EBITDA was down -10.23% on September 30, 2025
What is 1-year change in RNA quarterly EBITDA?
RNA quarterly EBITDA is down -92.71% year-over-year
How far is RNA quarterly EBITDA from its all-time high?
RNA quarterly EBITDA is currently -9194.55% below its historical high of -$2.02M set on March 31, 2019
How does RNA quarterly EBITDA rank versus sector peers?
RNA quarterly EBITDA is higher than 0.81% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
TTM EBITDA
-$609.06M$90.33M-17.41%
Summary
- Current Value
- As of today, RNA TTM EBITDA is -$609.06M, down -17.41% on
- Historical Performance
- RNA TTM EBITDA is down -89.13% year-over-year, and down -273.63% over the past 3 years
- All-Time High Comparison
- RNA TTM EBITDA is currently -30051.58% below its historical high of -$2.02M set on
- 3-Year Low Comparison
- RNA TTM EBITDA is at its 3-year low
- Sector Comparison
- RNA TTM EBITDA is higher than 0.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$609.06M | -17.4% | -89.1% | -273.6% | -1721.3% | |
| Annual EBITDA | -$376.16M | – | -61.1% | -220.4% | -2112.8% | |
| Quarterly EBITDA | -$187.75M | -10.2% | -92.7% | -321.6% | -1552.0% | |
| Price | $72.37 | +54.1% | +135.0% | +264.9% | +185.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $20.87M | +94.5% | +106.3% | +151.2% | +242.7% | |
| TTM EPS | -$4.17 | -17.2% | -43.9% | -27.8% | -306.3% | |
| TTM EBIT | -$612.46M | -17.4% | -88.6% | -272.9% | -1699.7% | |
| TTM Net Income | -$549.79M | -20.6% | -96.0% | -239.2% | -1328.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$376.16M | N/A | -61.9% |
| 3Y | -$177.52M | N/A | -243.1% |
| 5Y | -$43.90M | N/A | -1287.3% |
| All | -$2.02M | >-9999.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$609.06M | at low | |
| 3Y | -$609.06M | at low | |
| 5Y | -$609.06M | at low | |
| All | -$609.06M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RNA?
As of today, RNA TTM EBITDA is -$609.06M
What is RNA TTM EBITDA most recent change?
RNA TTM EBITDA was down -17.41% on September 30, 2025
What is 1-year change in RNA TTM EBITDA?
RNA TTM EBITDA is down -89.13% year-over-year
How far is RNA TTM EBITDA from its all-time high?
RNA TTM EBITDA is currently -30051.58% below its historical high of -$2.02M set on March 31, 2019
How does RNA TTM EBITDA rank versus sector peers?
RNA TTM EBITDA is higher than 0.90% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RNA Official Website www.aviditybiosciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990125000210/0001599901-25-000210-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990125000059/0001599901-25-000059-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna